User profiles for Michael S. Sinha

Michael S. Sinha, MD, JD, MPH

Saint Louis University School of Law
Verified email at slu.edu
Cited by 1605

[HTML][HTML] Covid-19—the law and limits of quarantine

WE Parmet, MS Sinha - New England Journal of Medicine, 2020 - Mass Medical Soc
… declares a public health emergency, as Secretary Alex Azar did on January 31, these orders
can be issued against persons in the precommunicable stage, which begins at a person’s

The opioid epidemic: fixing a broken pharmaceutical market

A Sarpatwari, MS Sinha, AS Kesselheim - Harv. L. & Pol'y Rev., 2017 - HeinOnline
On September 16, 2016, President Obama issued a proclamation decrying the US epidemic
of opioid misuse and abuse. Describing opioid use disorders as" a disease that touches too …

Personal protective equipment for COVID-19: distributed fabrication and additive manufacturing

MS Sinha, FT Bourgeois… - American Journal of …, 2020 - ajph.aphapublications.org
Widespread shortages of personal protective equipment (PPE) during the COVID-19 pandemic
have placed health care workers at risk and threatened their ability to care for patients. 1 …

Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE

…, D Plana, H Yang, MM Carmack, E Tian, MS Sinha… - Scientific reports, 2021 - nature.com
The COVID-19 pandemic has led to widespread shortages of personal protective equipment
(PPE) for healthcare workers, including of N95 masks (filtering facepiece respirators; FFRs). …

[PDF][PDF] Regulatory and safety considerations in deploying a locally fabricated, reusable face shield in a hospital responding to the COVID-19 pandemic

…, EW Boyer, A Fannin, J Freake, R Oakley, MS Sinha… - Med, 2020 - cell.com
Background Due to supply chain disruption, the COVID-19 pandemic has caused severe
shortages in personal protective equipment for health care professionals. Local fabrication …

Determinants of market exclusivity for prescription drugs in the United States

AS Kesselheim, MS Sinha, J Avorn - JAMA internal medicine, 2017 - jamanetwork.com
The high prices of brand-name prescription drugs are a growing source of controversy in the
United States. Manufacturers of brand-name drugs can command high prices because they …

Fentanyl panic goes viral: The spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media

…, S Seymour, S Kang, Z Siegel, MS Sinha… - International Journal of …, 2020 - Elsevier
Background Fueled by misinformation, fentanyl panic has harmed public health through
complicating overdose rescue while rationalizing hyper-punitive criminal laws, wasteful …

Labeling changes and costs for clinical trials performed under the US Food and Drug Administration pediatric exclusivity extension, 2007 to 2012

MS Sinha, M Najafzadeh, EK Rajasingh… - JAMA Internal …, 2018 - jamanetwork.com
Importance Pharmaceutical manufacturers can receive 6 additional months of market
exclusivity for performing pediatric clinical trials of brand-name drugs widely used in adults. …

Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion

…, NJ Michaels, KS Rawji, E Zhang, S Sinha… - Science …, 2020 - science.org
Microglia and infiltrating macrophages are thought to orchestrate the central nervous system
(CNS) response to injury; however, the similarities between these cells make it challenging …

Micro‐inequities in medicine

JK Silver, M Rowe, MS Sinha, DM Molinares… - PM&R, 2018 - Wiley Online Library
In this ethical legal column, the guest editor, Julie Silver, MD, focuses on the concept of
micro-inequities, a term coined by Mary Rowe, PhD (one of the invited columnists) more than 40 …